Objectives Since the introduction of Australia's human papillomavirus vaccination program,
the management rate of genital warts in sexual health clinics and private hospitals has …

Objectives. To detect decreases in anogenital warts (AGW) among sex and age groups
likely to be affected by human papillomavirus vaccination. Methods. We estimated annual …

Background Anogenital warts (AGW) are caused by the most common sexually transmitted
infection, human papillomavirus. The objective of this study was to examine AGW incidence …

Background We assessed the effectiveness of the quadrivalent human papillomavirus
vaccine (qHPV) vaccination program in Manitoba, Canada, in reducing incident anogenital …

Objectives: To examine messages US clinicians use when counseling patients diagnosed
with anogenital warts. Study Design: In mid-2004, we conducted a confidential mail survey …

Objectives The incidence of recurrent genital warts is not well characterized; this is
especially true in a post-human papillomavirus (HPV) vaccination era. The objectives of this …

Background Genital warts are important causes of morbidity and their prevalence and
incidence can be used to evaluate the impact of HPV vaccination in a population. Methods …

Importance Rates of human papillomavirus (HPV) infection have decreased since the
introduction of HPV vaccines in populations with high vaccine uptake. Data are limited for …

Purpose Human papillomavirus (HPV) vaccine is recommended for adolescents. By the end
of 2013, 64% of female and 40% of male New York City residents aged 13–18 years had …

Objective Trends in occurrence of anogenital warts (AGWs) can provide early evidence of
human papillomavirus (HPV) vaccination programme impact on preventing HPV infection …